Teschke R

Idioma: Ingles.
Referencias bibliográficas: 7
Paginas: 812-814
Archivo PDF: 115.85 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 205-23.

2. Musso G, Gambino R, Cassader M, Pagano GA. Metaanalysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43; 617-49.

3. Boyer TD, Haskal ZJ. AASLD Practice Guidelines: The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Hepatology 2010; 51: 1-16.

4. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplantant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47: 288-95.

5. Mendez-Sanchez N, García-Villegas E, Merino-Zeferino B, Ochoa-Cruz S, Villa AR, Madrigal H, Kobsahi-Margáin RA, et al. Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states. Ann Hepatol 20010; 9: 428-38.

6. Mendez-Sanchez N, Aquilar-Ramírez RJ, Reyes A, Dehesa M, Juárez A, Castaneda B, Sánchez-Avila F, et al. Etiology of liver cirrhosis in Mexcio. Ann Hepatol 2004; 3: 30-3.

7. AASLD/IDSA, HCV Guidance Panel. Hepatitis C Guidance: AASLD-IDSA reommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 2015; 62: 932-54.